Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001305253-16-000005
Filing Date
2016-04-29
Accepted
2016-04-28 18:04:07
Documents
1
Effectiveness Date
2016-04-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11947
  Complete submission text file 0001305253-16-000005.txt   13195
Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-272-6138
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

EIN.: 330971591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-262254 | Film No.: 161601552
SIC: 2836 Biological Products, (No Diagnostic Substances)